Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Biolase Debt to Equity Ratio 2010-2023 | BIOL

Current and historical debt to equity ratio values for Biolase (BIOL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Biolase debt/equity for the three months ending December 31, 2023 was 34.06.
  
Biolase Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $0.03B $0.00B 16.95
2023-09-30 $0.03B $0.01B 5.59
2023-06-30 $0.03B $0.01B 4.40
2023-03-31 $0.03B $0.01B 4.14
2022-12-31 $0.03B $0.01B 6.81
2022-09-30 $0.03B $0.01B 2.09
2022-06-30 $0.03B $0.02B 1.35
2022-03-31 $0.03B $0.02B 1.44
2021-12-31 $0.03B $0.03B 1.19
2021-09-30 $0.03B $0.03B 0.93
2021-06-30 $0.03B $0.03B 0.84
2021-03-31 $0.03B $0.03B 0.89
2020-12-31 $0.03B $0.01B 3.09
2020-09-30 $0.03B $0.01B 2.03
2020-06-30 $0.03B $0.00B 20.20
2020-03-31 $0.03B $-0.00B -28.53
2019-12-31 $0.03B $0.00B 6.34
2019-09-30 $0.03B $-0.00B -27.52
2019-06-30 $0.03B $0.00B 7.53
2019-03-31 $0.03B $0.01B 3.85
2018-12-31 $0.03B $0.01B 2.47
2018-09-30 $0.02B $0.02B 1.10
2018-06-30 $0.02B $0.02B 0.75
2018-03-31 $0.02B $0.03B 0.62
2017-12-31 $0.01B $0.03B 0.47
2017-09-30 $0.02B $0.02B 0.77
2017-06-30 $0.02B $0.03B 0.67
2017-03-31 $0.02B $0.02B 1.02
2016-12-31 $0.02B $0.02B 0.90
2016-09-30 $0.02B $0.03B 0.71
2016-06-30 $0.02B $0.02B 0.90
2016-03-31 $0.02B $0.02B 0.78
2015-12-31 $0.02B $0.03B 0.70
2015-09-30 $0.02B $0.03B 0.79
2015-06-30 $0.02B $0.03B 0.65
2015-03-31 $0.02B $0.04B 0.47
2014-12-31 $0.02B $0.04B 0.41
2014-09-30 $0.02B $0.01B 1.69
2014-06-30 $0.02B $0.00B 8.09
2014-03-31 $0.02B $0.01B 2.18
2013-12-31 $0.02B $0.01B 2.66
2013-09-30 $0.02B $0.01B 2.46
2013-06-30 $0.02B $0.01B 2.98
2013-03-31 $0.02B $0.01B 2.15
2012-12-31 $0.02B $0.01B 1.71
2012-09-30 $0.02B $0.01B 1.79
2012-06-30 $0.02B $0.01B 1.66
2012-03-31 $0.02B $0.01B 1.34
2011-12-31 $0.02B $0.01B 1.37
2011-09-30 $0.02B $0.01B 1.06
2011-06-30 $0.02B $0.02B 1.01
2011-03-31 $0.02B $0.00B 3.68
2010-12-31 $0.02B $-0.00B -6.96
2010-09-30 $0.02B $-0.00B -6.50
2010-06-30 $0.02B $-0.00B -16.56
2010-03-31 $0.02B $0.00B 6.19
2009-12-31 $0.01B $0.01B 1.80
2009-09-30 $0.01B $0.01B 1.54
2009-06-30 $0.02B $0.01B 1.90
2009-03-31 $0.02B $0.01B 3.50
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.005B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $69.909B 18.71
Becton Dickinson (BDX) United States $67.707B 19.66
West Pharmaceutical Services (WST) United States $28.565B 48.29
Cardinal Health (CAH) United States $25.143B 15.11
Align Technology (ALGN) United States $23.470B 47.33
Cooper (COO) United States $18.222B 27.57
Labcorp (LH) United States $17.496B 14.94
Henry Schein (HSIC) United States $9.348B 16.17
DENTSPLY SIRONA (XRAY) United States $6.399B 16.86
Merit Medical Systems (MMSI) United States $4.307B 24.65
STAAR Surgical (STAA) United States $2.355B 74.14
Patterson (PDCO) United States $2.327B 11.15
CONMED (CNMD) United States $2.196B 20.67
Atrion (ATRI) United States $0.713B 36.74
Lifevantage (LFVN) United States $0.082B 13.34
Pro-Dex (PDEX) United States $0.066B 25.00